chr22-50529311-C-T

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 3P and 9B. PM1PP3BP6BS1BS2

The NM_001953.5(TYMP):​c.242G>A​(p.Arg81Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00169 in 1,613,376 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/24 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0013 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0017 ( 3 hom. )

Consequence

TYMP
NM_001953.5 missense

Scores

2
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:6

Conservation

PhyloP100: -0.287

Publications

9 publications found
Variant links:
Genes affected
TYMP (HGNC:3148): (thymidine phosphorylase) This gene encodes an angiogenic factor which promotes angiogenesis in vivo and stimulates the in vitro growth of a variety of endothelial cells. It has a highly restricted target cell specificity acting only on endothelial cells. Mutations in this gene have been associated with mitochondrial neurogastrointestinal encephalomyopathy. Multiple alternatively spliced transcript variants have been identified. [provided by RefSeq, Apr 2012]
TYMP Gene-Disease associations (from GenCC):
  • mitochondrial disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • mitochondrial DNA depletion syndrome 1
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • mitochondrial neurogastrointestinal encephalomyopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 8 uncertain in NM_001953.5
PP3
Splicing predictors support a deleterious effect. Scorers claiming Pathogenic: max_spliceai. No scorers claiming Uncertain. No scorers claiming Benign.
BP6
Variant 22-50529311-C-T is Benign according to our data. Variant chr22-50529311-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 137872.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00131 (200/152312) while in subpopulation AMR AF = 0.00209 (32/15306). AF 95% confidence interval is 0.00163. There are 0 homozygotes in GnomAd4. There are 93 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TYMPNM_001953.5 linkc.242G>A p.Arg81Gln missense_variant Exon 3 of 10 ENST00000252029.8 NP_001944.1 P19971-1E5KRG5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TYMPENST00000252029.8 linkc.242G>A p.Arg81Gln missense_variant Exon 3 of 10 1 NM_001953.5 ENSP00000252029.3 P19971-1

Frequencies

GnomAD3 genomes
AF:
0.00131
AC:
200
AN:
152194
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000507
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00209
Gnomad ASJ
AF:
0.00259
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000470
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00190
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.00130
AC:
325
AN:
249984
AF XY:
0.00125
show subpopulations
Gnomad AFR exome
AF:
0.000434
Gnomad AMR exome
AF:
0.00127
Gnomad ASJ exome
AF:
0.00330
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000697
Gnomad NFE exome
AF:
0.00190
Gnomad OTH exome
AF:
0.00197
GnomAD4 exome
AF:
0.00173
AC:
2528
AN:
1461064
Hom.:
3
Cov.:
32
AF XY:
0.00163
AC XY:
1182
AN XY:
726878
show subpopulations
African (AFR)
AF:
0.000358
AC:
12
AN:
33476
American (AMR)
AF:
0.00157
AC:
70
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.00367
AC:
96
AN:
26130
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39694
South Asian (SAS)
AF:
0.0000348
AC:
3
AN:
86246
European-Finnish (FIN)
AF:
0.000550
AC:
29
AN:
52684
Middle Eastern (MID)
AF:
0.000693
AC:
4
AN:
5768
European-Non Finnish (NFE)
AF:
0.00198
AC:
2201
AN:
1111978
Other (OTH)
AF:
0.00186
AC:
112
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
162
325
487
650
812
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
82
164
246
328
410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00131
AC:
200
AN:
152312
Hom.:
0
Cov.:
33
AF XY:
0.00125
AC XY:
93
AN XY:
74478
show subpopulations
African (AFR)
AF:
0.000505
AC:
21
AN:
41548
American (AMR)
AF:
0.00209
AC:
32
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00259
AC:
9
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.000470
AC:
5
AN:
10630
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00190
AC:
129
AN:
68018
Other (OTH)
AF:
0.00142
AC:
3
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
10
21
31
42
52
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00156
Hom.:
1
Bravo
AF:
0.00148
TwinsUK
AF:
0.00243
AC:
9
ALSPAC
AF:
0.00130
AC:
5
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.00174
AC:
15
ExAC
AF:
0.00111
AC:
135
EpiCase
AF:
0.00207
EpiControl
AF:
0.00202

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:6
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:3
Nov 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

TYMP: BP4 -

Jun 15, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 20, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mitochondrial DNA depletion syndrome 1 Uncertain:1Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -

Feb 25, 2021
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
May 05, 2014
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

TYMP-related disorder Benign:1
Mar 28, 2022
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.069
BayesDel_addAF
Benign
-0.46
T
BayesDel_noAF
Benign
-0.44
CADD
Benign
18
DANN
Benign
0.87
DEOGEN2
Uncertain
0.48
T;.;T;T;T
Eigen
Benign
-1.9
Eigen_PC
Benign
-2.0
FATHMM_MKL
Benign
0.037
N
LIST_S2
Benign
0.77
.;T;.;T;D
M_CAP
Benign
0.059
D
MetaRNN
Benign
0.0096
T;T;T;T;T
MetaSVM
Benign
-0.59
T
MutationAssessor
Benign
0.23
N;N;N;N;.
PhyloP100
-0.29
PrimateAI
Benign
0.22
T
PROVEAN
Benign
-1.8
N;N;N;N;N
REVEL
Uncertain
0.29
Sift
Benign
0.45
T;T;T;T;T
Sift4G
Benign
0.27
T;T;T;T;T
Polyphen
0.23
B;.;B;B;.
Vest4
0.11
MVP
0.53
MPC
0.51
ClinPred
0.0090
T
GERP RS
-8.5
Varity_R
0.088
gMVP
0.57
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.51
Details are displayed if max score is > 0.2
DS_AG_spliceai
0.51
Position offset: -2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs143789597; hg19: chr22-50967740; COSMIC: COSV52688306; COSMIC: COSV52688306; API